» Articles » PMID: 30254073

Dimerization Interface of Osteoprotegerin Revealed by Hydrogen-deuterium Exchange Mass Spectrometry

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2018 Sep 27
PMID 30254073
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Previous structural studies of osteoprotegerin (OPG), a crucial negative regulator of bone remodeling and osteoclastogenesis, were mostly limited to the N-terminal ligand-binding domains. It is now known that the three C-terminal domains of OPG also play essential roles in its function by mediating OPG dimerization, OPG-heparan sulfate (HS) interactions, and formation of the OPG-HS-receptor activator of nuclear factor κB ligand (RANKL) ternary complex. Employing hydrogen-deuterium exchange MS methods, here we investigated the structure of full-length OPG in complex with HS or RANKL in solution. Our data revealed two noteworthy aspects of the OPG structure. First, we found that the interconnection between the N- and C-terminal domains is much more rigid than previously thought, possibly because of hydrophobic interactions between the fourth cysteine-rich domain and the first death domain. Second, we observed that two hydrophobic clusters located in two separate C-terminal domains directly contribute to OPG dimerization, likely by forming a hydrophobic dimerization interface. Aided by site-directed mutagenesis, we further demonstrated that an intact dimerization interface is essential for the biological activity of OPG. Our study represents an important step toward deciphering the structure-function relationship of the full-length OPG protein.

Citing Articles

Biochemical characterization of a disease-causing human osteoprotegerin variant.

Luo Y, Li M, Xu D Sci Rep. 2022; 12(1):15279.

PMID: 36088403 PMC: 9464236. DOI: 10.1038/s41598-022-19522-9.


Rank-Rankl-Opg Axis in Multiple Sclerosis: The Contribution of Placenta.

Passaponti S, Ermini L, Acconci G, Severi F, Romagnoli R, Cutrupi S Cells. 2022; 11(8).

PMID: 35456036 PMC: 9031903. DOI: 10.3390/cells11081357.


Structures of mouse and human GITR-GITRL complexes reveal unique TNF superfamily interactions.

Wang F, Chau B, West S, Kimberlin C, Cao F, Schwarz F Nat Commun. 2021; 12(1):1378.

PMID: 33654081 PMC: 7925557. DOI: 10.1038/s41467-021-21563-z.


Antiresorptive activity of osteoprotegerin requires an intact heparan sulfate-binding site.

Li M, Xu D Proc Natl Acad Sci U S A. 2020; 117(29):17187-17194.

PMID: 32636266 PMC: 7382260. DOI: 10.1073/pnas.2005859117.

References
1.
Zhang J, Ogorzalek Loo R, Loo J . Increasing Fragmentation of Disulfide-Bonded Proteins for Top-Down Mass Spectrometry by Supercharging. Int J Mass Spectrom. 2015; 377:546-556. PMC: 4448141. DOI: 10.1016/j.ijms.2014.07.047. View

2.
Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y . Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology. 2000; 141(9):3478-84. DOI: 10.1210/endo.141.9.7634. View

3.
Percy A, Rey M, Burns K, Schriemer D . Probing protein interactions with hydrogen/deuterium exchange and mass spectrometry-a review. Anal Chim Acta. 2012; 721:7-21. DOI: 10.1016/j.aca.2012.01.037. View

4.
Anderson J, Hernandez G, LeMaster D . A billion-fold range in acidity for the solvent-exposed amides of Pyrococcus furiosus rubredoxin. Biochemistry. 2008; 47(23):6178-88. DOI: 10.1021/bi800284y. View

5.
Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T . Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun. 1997; 234(1):137-42. DOI: 10.1006/bbrc.1997.6603. View